| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.2757 | 14 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.7217 | 35 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.0016 | 32 |
| GSM780719 | Untreated after 4 days (C1_2) | 37.3196 | 2 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.8565 | 36 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.6118 | 20 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 40.6918 | 8 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 39.466 | 5 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 40.254 | 7 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 40.2827 | 7 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 42.6944 | 16 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.1225 | 23 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 47.2364 | 38 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.0971 | 37 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.4035 | 19 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 36.3497 | 1 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.253 | 49 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.253 | 23 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 40.0016 | 6 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.0767 | 18 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.3576 | 19 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 41.2178 | 10 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 39.2608 | 5 |